Replies to post #338125 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Well, not an Anavex matter.

One minor correction, SA4503, cutamesine, is not an Anavex compound, but it has been shown to be a sigma 1 receptor agonist.

George, thank you very much. Very clearly, this is not a direct indication of how any of the specific Anavex molecules might modulate ALS.

This puts ALS even lower on the long list of potential CNS diseases or conditions that Anavex might eventually target with their proprietary sigma-1 receptor activators. Plenty of ones at the top to bring commercial success: Rett syndrome, Parkinson's disease dementia, and Alzheimer's, etc.